Loading organizations...
Key people at Flying L Partners.
Flying L Partners is a venture capital firm based in Newport Beach, California, that specializes in early-stage healthcare investments with a specific focus on ophthalmology and medical devices. The organization primarily allocates capital to businesses developing novel therapeutics, surgical instruments, and innovative technologies aimed at improving human vision and curing complex eye diseases. Operating through a closed fund business model, the firm successfully closed three distinct investment vehicles between March and October of 2019 to back emerging vision care enterprises. Across its operational history, the firm has deployed capital into nearly 30 ophthalmic companies, supporting their clinical development and commercialization efforts. The firm's historical and current investment portfolio features several recognizable medical device and pharmaceutical entities, including Glaukos, RxSight, AcuFocus, Tarsus Pharmaceuticals, and IntraLase. Flying L Partners was established in 2016 and was founded by managing partner William Link.
Key people at Flying L Partners.
Flying L Partners has 4 tracked investments across 4 companies. The latest tracked deal is $120.0M Series U in Aurion Biotechnologies in April 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2022 | Aurion Biotechnologies | $120.0M Series U | Deerfield Management | Alcon, Falcon Vision, Patrick Lally, Visionary Ventures |
| Aug 12, 2020 | TearClear | $22.0M Series B | — | Bluestem Capital, Falcon Vision, Visionary Ventures |
| Jan 8, 2020 | Tarsus Pharmaceuticals | $60.0M Series B | Chen YU | Aperture Venture Partners, Frazier Healthcare Partners, Horowitz Group, Visionary Ventures |
| May 15, 2018 | Surface Ophthalmics | $20.0M Series A | Flying L Partners | — |
